Investigational HIV therapeutic vaccine found to control SIV in preclinical studies

Researchers have found that an investigational treatment combining therapeutic vaccine and an immune stimulator was successful for improving virologic control and delay viral rebound after the discontinuation of anti-retroviral therapy (ART).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news